SCHEMBL7202158

SCHEMBL7202158

c1ccc(N2CCc3ccc(N4CCNCC4)cc32)cc1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR6 P50406 7/20 0.61
DRD3 P35462 3/20 0.61
ADRB1 P08588 6/20 0.54
HTR3E A5X5Y0 3/20 0.54
HTR3B O95264 3/20 0.54
HTR3A P46098 3/20 0.54
HTR3D Q70Z44 3/20 0.54
HTR3C Q8WXA8 3/20 0.54
SIGMAR1 Q99720 3/20 0.54
HTR1A P08908 2/20 0.53
HTR7 P34969 2/20 0.53
HTR5A P47898 1/20 0.50
HTR2C P28335 2/20 0.49
TP53 P04637 1/20 0.46
CYP1A2 P05177 1/20 0.46
CYP3A4 P08684 1/20 0.46
CYP2D6 P10635 1/20 0.46
THRB P10828 1/20 0.46
CYP2C9 P11712 1/20 0.46
HTR2A P28223 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3239201 0.74 ADRB1 (0.47) HTR6DRD3ADRB1HTR3EHTR3B
SCHEMBL5349708 0.73 HTR6 (0.51) HTR6DRD3ADRB1HTR3EHTR3B
SCHEMBL24011964 0.73 MAP3K14 (0.51) SIGMAR1HTR2CCYP1A2CYP3A4CYP2D6
SCHEMBL2097897 0.73 ESR2 (0.46) DRD3HTR2ADRD2
Phenylpiperazine SCHEMBL27858598 0.73 ADRB1 (1.00) HTR6ADRB1HTR3EHTR3BHTR3A
Phenylpiperazine SCHEMBL24889 0.73 ADRB1 (1.00) HTR6ADRB1HTR3EHTR3BHTR3A
Phenylpiperazine SCHEMBL29135595 0.73 ADRB1 (1.00) HTR6ADRB1HTR3EHTR3BHTR3A
Phenylpiperazine SCHEMBL55125 0.73 ADRB1 (1.00) HTR6ADRB1HTR3EHTR3BHTR3A
Hydrochloric Acid SCHEMBL7235786 0.72 NPC1 (0.54) HTR6DRD3ADRB1HTR3EHTR3B
Phenylpiperazine SCHEMBL29235019 0.72 ADRB1 (0.80) HTR6DRD3ADRB1HTR3EHTR3B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6599904-B2 5-HT6 receptor antagonists are believed to be of potential use in the treatment of certain CNS disorders; cognitive memory enhancement SMITHKLINE BEECHAM P.L.C. (GB) 2003-07-29 US disclosed